HEPATOLOGÍA EXPERIMENTAL Y VECTORIZACIÓN DE FÁRMACOS
HEVEFARM
University of Milano-Bicocca
Milán, ItaliaPublicaciones en colaboración con investigadores/as de University of Milano-Bicocca (6)
2021
-
Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic
Expert Opinion on Investigational Drugs, Vol. 30, Núm. 4, pp. 377-388
-
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: A systematic review and individual participant data meta-analysis
Obstetrical and Gynecological Survey
-
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis
The Lancet Gastroenterology and Hepatology, Vol. 6, Núm. 7, pp. 547-558
2019
-
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: Results of aggregate and individual patient data meta-analyses
Obstetrical and Gynecological Survey
-
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses
The Lancet, Vol. 393, Núm. 10174, pp. 899-909
2016
-
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Nature Reviews Gastroenterology and Hepatology, Vol. 13, Núm. 5, pp. 261-280